Institute of Natural Medicine, University of Toyama, 2630-Sugitani, Toyama, 930-0194, Japan.
Department of Chemistry, University of Yangon, Yangon, 11041, Myanmar.
J Nat Med. 2023 Sep;77(4):891-897. doi: 10.1007/s11418-023-01731-9. Epub 2023 Jul 18.
Arginases are bimanganese enzymes involved in many human illnesses, and thus are targets for disease treatments. The screening of traditional medicinal plants demonstrated that an ethanol extract of Curcuma comosa rhizomes showed significant human arginase I and II inhibitory activity, and further fractionation led to the isolation of three known guaiane sesquiterpenoids, alismoxide (1), 7α,10α-epoxyguaiane-4α,11-diol (2) and guaidiol (3). Tests of their inhibitory activities on human arginases I and II revealed that 1 exhibited selective and potent competitive inhibition for human arginase I (IC = 30.2 μM), whereas the other compounds lacked inhibitory activities against human arginases. To the best of our knowledge, this is the first demonstration of human arginase I inhibitory activity by a sesquiterpenoid. Thus, 1 is a primary and specific inhibitory molecule against human arginase I.
精氨酸酶是参与许多人类疾病的双锰酶,因此是疾病治疗的靶点。对传统药用植物的筛选表明,菖蒲根茎的乙醇提取物对人精氨酸酶 I 和 II 具有显著的抑制活性,进一步的分离得到了三种已知的愈创木烷倍半萜,阿里莫德(1)、7α,10α-环氧愈创木烷-4α,11-二醇(2)和愈创木醇(3)。它们对人精氨酸酶 I 和 II 的抑制活性测试表明,1 对人精氨酸酶 I 表现出选择性和强效的竞争性抑制作用(IC=30.2μM),而其他化合物对人精氨酸酶没有抑制活性。据我们所知,这是倍半萜对人精氨酸酶 I 抑制活性的首次证明。因此,1 是一种针对人精氨酸酶 I 的主要和特异性抑制分子。